Genocea Biosciences Inc
OTC:GNCAQ
Income Statement
Earnings Waterfall
Genocea Biosciences Inc
Income Statement
Genocea Biosciences Inc
| Dec-2018 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
0
N/A
|
1
N/A
|
2
+21%
|
|
| Operating Income | ||||
| Operating Expenses |
(40)
|
(48)
|
(54)
|
|
| Selling, General & Administrative |
(14)
|
(14)
|
(15)
|
|
| Research & Development |
(25)
|
(34)
|
(39)
|
|
| Operating Income |
(40)
N/A
|
(47)
-19%
|
(52)
-11%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
14
|
8
|
19
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
|
| Total Other Income |
(2)
|
(4)
|
(0)
|
|
| Pre-Tax Income |
(28)
N/A
|
(44)
-57%
|
(33)
+24%
|
|
| Net Income | ||||
| Income from Continuing Operations |
(28)
|
(44)
|
(33)
|
|
| Net Income (Common) |
(28)
N/A
|
(44)
-57%
|
(33)
+24%
|
|
| EPS (Diluted) |
-2.69
N/A
|
-0.98
+64%
|
-0.48
+51%
|
|